These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17346943)

  • 21. CSF hypocretin-1/orexin-A concentrations in patients with subarachnoid hemorrhage (SAH).
    Dohi K; Ripley B; Fujiki N; Ohtaki H; Shioda S; Aruga T; Nishino S
    Peptides; 2005 Nov; 26(11):2339-43. PubMed ID: 15893406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Orexin expression and promoter-methylation in peripheral blood of patients suffering from major depressive disorder.
    Rotter A; Asemann R; Decker A; Kornhuber J; Biermann T
    J Affect Disord; 2011 Jun; 131(1-3):186-92. PubMed ID: 21211849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced platelet BDNF level in patients with major depression.
    Lee BH; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(5):849-53. PubMed ID: 19371767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CSF 5-HIAA and DST non-suppression--orthogonal biologic risk factors for suicide in male mood disorder inpatients.
    Jokinen J; Nordström AL; Nordström P
    Psychiatry Res; 2009 Jan; 165(1-2):96-102. PubMed ID: 19062105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased aldosterone in the plasma of suicide attempters with major depressive disorder.
    Hallberg L; Westrin A; Isaksson A; Janelidze S; Träskman-Bendz L; Brundin L
    Psychiatry Res; 2011 May; 187(1-2):135-9. PubMed ID: 20797799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disentangling dysthymia from major depressive disorder in suicide attempters' suicidality, comorbidity and symptomatology.
    Holmstrand C; Engström G; Träskman-Bendz L
    Nord J Psychiatry; 2008; 62(1):25-31. PubMed ID: 18389422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased cerebrospinal fluid hypocretin-1 (orexin A) in patients after repetitive generalized tonic-clonic seizures.
    Rejdak K; Papuć E; Grieb P; Stelmasiak Z
    Epilepsia; 2009 Jun; 50(6):1641-4. PubMed ID: 19175390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrospinal fluid hypocretin-1 levels during the active period of cluster headache.
    Cevoli S; Pizza F; Grimaldi D; Nicodemo M; Favoni V; Pierangeli G; Valko PO; Baumann CR; Montagna P; Bassetti CL; Cortelli P
    Cephalalgia; 2011 Jun; 31(8):973-6. PubMed ID: 21444644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain orexins and wake regulation in rats exposed to maternal deprivation.
    Feng P; Vurbic D; Wu Z; Strohl KP
    Brain Res; 2007 Jun; 1154():163-72. PubMed ID: 17466285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A patient with anti-aquaporin 4 antibody who presented with recurrent hypersomnia, reduced orexin (hypocretin) level, and symmetrical hypothalamic lesions.
    Nozaki H; Shimohata T; Kanbayashi T; Sagawa Y; Katada S; Satoh M; Onodera O; Tanaka K; Nishizawa M
    Sleep Med; 2009 Feb; 10(2):253-5. PubMed ID: 18226957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CSF orexin A concentrations and expressions of the orexin-1 receptor in rat hippocampus after cardiac arrest.
    Dohi K; Nishino S; Nakamachi T; Ohtaki H; Morikawa K; Takeda T; Shioda S; Aruga T
    Neuropeptides; 2006 Aug; 40(4):245-50. PubMed ID: 16930690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High delta sleep-inducing peptide-like immunoreactivity in plasma in suicidal patients with major depressive disorder.
    Westrin A; Ekman R; Träskman-Bendz L
    Biol Psychiatry; 1998 May; 43(10):734-9. PubMed ID: 9606527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal fluid hypocretin-1 levels in multiple system atrophy.
    Martinez-Rodriguez JE; Seppi K; Cardozo A; Iranzo A; Stampfer-Kountchev M; Wenning G; Tolosa E; Högl B; Santamaria J; Poewe W;
    Mov Disord; 2007 Sep; 22(12):1822-4. PubMed ID: 17659646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cocaine and amphetamine regulated transcript (CART) in suicide attempters.
    Brundin L; Björkqvist M; Träskman-Bendz L; Petersén A
    Psychiatry Res; 2008 Mar; 158(2):117-22. PubMed ID: 18096245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute cerebral ischaemia: relationship between serum and cerebrospinal fluid orexin-A concentration and infarct volume.
    Kotan D; Deniz O; Aygul R; Yildirim A
    J Int Med Res; 2013 Apr; 41(2):404-9. PubMed ID: 23569032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Normal hypocretin-1 (orexin A) levels in cerebrospinal fluid in patients with idiopathic intracranial hypertension.
    Poca MA; Galard R; Serrano E; Merino MA; Pozo-Rosich P; Solana E; Mestres O; de la Calzada MD; Sahuquillo J
    Acta Neurochir Suppl; 2012; 114():221-5. PubMed ID: 22327697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low cerebrospinal fluid and plasma orexin-A (hypocretin-1) concentrations in combat-related posttraumatic stress disorder.
    Strawn JR; Pyne-Geithman GJ; Ekhator NN; Horn PS; Uhde TW; Shutter LA; Baker DG; Geracioti TD
    Psychoneuroendocrinology; 2010 Aug; 35(7):1001-7. PubMed ID: 20116928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypocretin (orexin) loss in Parkinson's disease.
    Fronczek R; Overeem S; Lee SY; Hegeman IM; van Pelt J; van Duinen SG; Lammers GJ; Swaab DF
    Brain; 2007 Jun; 130(Pt 6):1577-85. PubMed ID: 17470494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Normal hypocretin-1 (orexin-A) levels in the cerebrospinal fluid of patients with Huntington's disease.
    Meier A; Mollenhauer B; Cohrs S; Rodenbeck A; Jordan W; Meller J; Otto M
    Brain Res; 2005 Nov; 1063(2):201-3. PubMed ID: 16263095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High CSF-insulin in violent suicide attempters.
    Westling S; Ahrén B; Träskman-Bendz L; Westrin A
    Psychiatry Res; 2004 Dec; 129(3):249-55. PubMed ID: 15661318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.